Inj Human Papilloma Virus 9-Valent Vaccine, Recombinant (Serotypes: Type 6L1, 11L1,... Tender

NORTHEAST FRONTIER RAILWAY has floated a tender for Inj Human Papilloma Virus 9-Valent Vaccine, Recombinant (Serotypes: Type 6L1, 11L1, 16L1, 18L1, 31L1, 33L1, 45L1, 52L1 & 58L1 ) 0.5Ml in Pfs. The project location is Guwahati, Assam, India. The reference number is 202526ELTM189 and it is closing on 15 Jul 2025. Suppliers can request Register free of cost to get the complete Tender details and download the document.

Expired Tender

Procurement Summary

State : Assam

Summary : Inj Human Papilloma Virus 9-Valent Vaccine, Recombinant (Serotypes: Type 6L1, 11L1, 16L1, 18L1, 31L1, 33L1, 45L1, 52L1 & 58L1 ) 0.5Ml in Pfs

Deadline : 15 Jul 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 122520848

Document Ref. No. : 202526ELTM189

Financier : Self Financed

Purchaser Ownership : Public

Document Fees : Refer Document

Tender Value : Refer Document

EMD : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Inj Human Papilloma Virus 9-Valent Vaccine, Recombinant (Serotypes: Type 6 L1, 11L1, 16L1, 18L1, 31L1, 33L1, 45L1, 52L1 & 58L1 ) 0.5Ml in Pfs ]
Contract Category: Expenditure
Contract Type : Goods
Tender Type : Limited - Indigenous
Contract Category : Expenditure
Evaluation Criteria : Itemwise/Consigneewise
Bidding System : Single Packet
Pre-Bid Conference Required : No
Pre-Bid Conference Date Time : Not Applicable
Tendering Section : PUR
Inspection Agency : CONSIGNEE
Publishing Date / Time : 11/07/2025 15:42 Item Category General
Procure From Approved Sources : No
Approving Agency : Not Applicable
Closing Date Time : 15/07/2025 12:00
Validity of Offer ( Days) : 120
Ranking Order for Bids : Lowest to Highest
Advertised Value :
Tender Doc. Cost (INR) : 0.00
Earnest Money (INR) : 0.00

Consignee MLG Assam 200.00 Numbers

Documents

 Tender Notice

viewNitPdf_5037968.pdf

TENDER-TERMS--CONDITION--NFR_1.pdf